| 摘要 |
<p>Described is the novel use of highly fucosylated glycoconjugates as active ingredient in the preparation of a medicament for treatement of classical complement involved conditions, for antimetastatic therapies and as targeting vehicle to target a drug to cells, expressing E- and/or P-selectin. Further, novel highly fucosylated glycoconjugates are described.</p> |
